Hospital Acquired Infection Control Market by Type (Consumables, Disinfectants, Disinfectors), Pathogen (Bacterial, Fungal, Viral), Indication, End User - Global Forecast 2024-2030

Hospital Acquired Infection Control Market by Type (Consumables, Disinfectants, Disinfectors), Pathogen (Bacterial, Fungal, Viral), Indication, End User - Global Forecast 2024-2030


The Hospital Acquired Infection Control Market size was estimated at USD 33.98 billion in 2023 and expected to reach USD 36.00 billion in 2024, at a CAGR 6.04% to reach USD 51.23 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hospital Acquired Infection Control Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hospital Acquired Infection Control Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hospital Acquired Infection Control Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Sterilization Products Services Inc., Becton, Dickinson and Company, Belimed AG, BioMerieux SA, Cantel Medical Corporation, F. Hoffmann-La Roche Ltd, Kimberly-Clark Corporation, Merck & Co., Inc., Olympus Corporation, Pfizer Inc., Sterigenics International LLC., Steris Corporation, Synergy Health, PLC, and The 3M Company.

Market Segmentation & Coverage



This research report categorizes the Hospital Acquired Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Consumables
Disinfectants
Disinfectors
Endoscope Reprocessors
Infection Prevention & Surveillance Software
Microbial Testing Instruments
Reagents
Sterilizers
Pathogen
Bacterial
Fungal
Viral
Indication
Bloodstream Infections
Gastrointestinal Infections
Hospital Acquired Pneumonia
Surgical Site Infections
Urinary Tract Infections
End User
Ambulatory Surgical & Diagnostic Centers
Hospitals & ICUs
Nursing Homes & Maternity Centers
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Hospital Acquired Infection Control Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hospital Acquired Infection Control Market?
3. What are the technology trends and regulatory frameworks in the Hospital Acquired Infection Control Market?
4. What is the market share of the leading vendors in the Hospital Acquired Infection Control Market?
5. Which modes and strategic moves are suitable for entering the Hospital Acquired Infection Control Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Hospital Acquired Infection Control Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing geriatric population with the increase in the number of chronic diseases
5.1.1.2. Rapidly growing emphasis on infection control policies
5.1.1.3. Increasing use of disinfectors and medical nonwovens in the healthcare industry
5.1.2. Restraints
5.1.2.1. Adverse Effects of Disinfectants and Sterilization
5.1.3. Opportunities
5.1.3.1. Increasing investments in R&D coupled with high usage of consumables in hospitals
5.1.3.2. Innovative technologies implemented in devices that control infection
5.1.4. Challenges
5.1.4.1. Stringent Regulatory Requirements for Hospital Acquired Infection
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Hospital Acquired Infection Control Market, by Type
6.1. Introduction
6.2. Consumables
6.3. Disinfectants
6.4. Disinfectors
6.5. Endoscope Reprocessors
6.6. Infection Prevention & Surveillance Software
6.7. Microbial Testing Instruments
6.8. Reagents
6.9. Sterilizers
7. Hospital Acquired Infection Control Market, by Pathogen
7.1. Introduction
7.2. Bacterial
7.3. Fungal
7.4. Viral
8. Hospital Acquired Infection Control Market, by Indication
8.1. Introduction
8.2. Bloodstream Infections
8.3. Gastrointestinal Infections
8.4. Hospital Acquired Pneumonia
8.5. Surgical Site Infections
8.6. Urinary Tract Infections
9. Hospital Acquired Infection Control Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical & Diagnostic Centers
9.3. Hospitals & ICUs
9.4. Nursing Homes & Maternity Centers
10. Americas Hospital Acquired Infection Control Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Hospital Acquired Infection Control Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Hospital Acquired Infection Control Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Advanced Sterilization Products Services Inc.
14.1.3. Becton, Dickinson and Company
14.1.4. Belimed AG
14.1.5. BioMerieux SA
14.1.6. Cantel Medical Corporation
14.1.7. F. Hoffmann-La Roche Ltd
14.1.8. Kimberly-Clark Corporation
14.1.9. Merck & Co., Inc.
14.1.10. Olympus Corporation
14.1.11. Pfizer Inc.
14.1.12. Sterigenics International LLC.
14.1.13. Steris Corporation
14.1.14. Synergy Health, PLC
14.1.15. The 3M Company
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET RESEARCH PROCESS
FIGURE 2. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2023 VS 2030
FIGURE 3. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HOSPITAL ACQUIRED INFECTION CONTROL MARKET DYNAMICS
FIGURE 7. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN, 2023 VS 2030 (%)
FIGURE 10. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings